US 7476382
Reovirus for the treatment of neoplasia
granted A61KA61K35/765A61P
Quick answer
US patent 7476382 (Reovirus for the treatment of neoplasia) held by ONCOLYTICS BIOTECH INC. expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K35/765, A61P, A61P35/00, A61P35/02